Name

Molecular mass (g/mol)

Selective Target

FDA approved

Cancer (example)

Afatinib

485.94

HER2, EGFR

Yes

Squamous cell arcinoma 0f head and neck, breast cancer

Crizotinib

450.34

MET

Yes

Anaplastic large cell lymphoma, Neuroblastoma

Eroltinib

393.43

EGFR

Yes

NSCLC, AML

Icotinib

391.15

RGFR

Yes

NSCLC

Lepatinib

581.06

HER2, EGFR

Yes

Breast cancer

Lenvatinib

426.85

VEGFR 2,3

Yes

Thyroid cancer